Colinz Laboratories Ltd.

Financial

	Colinz Laboratories	Venmax Drugs&Pharma	Link Pharma Chem
Operational Metrics
Financials
5 yr Average ROE	4.05 %	-44.32 %	4.87 %
5yr average Equity Multiplier	1.3	-0.19	1.96
5yr Average Asset Turnover Ratio	0.7	0.32	1.37
5yr Avg Net Profit Margin	4.66 %	-30.94 %	1.5 %
Price to Book	1.5	0.0	1.09
P/E	28.48	0.0	0.0
5yr Avg Cash Conversion Cycle	-0.66 Days	0.0	74.76 Days
Inventory Days	64.79 Days	24.83 Days	54.27 Days
Days Receivable	51.75 Days	0.0	53.6 Days
Days Payable	78.66 Days	189.56 Days	92.46 Days
5yr Average Interest Coverage Ratio	9.16	-318.36	3.51
5yr Avg ROCE	6.01 %	-45.33 %	8.64 %
5yr Avg Operating Profit Margin	6.82 %	-50.41 %	5.7 %
5 yr average Debt to Equity	0.07	-0.64	0.46
5yr CAGR Net Profit	30.39 %	n/a	n/a
5yr Average Return on Assets	3.14 %	187.49 %	2.49 %
Shareholdings
Promoter Holding	65.94 %	23.13 %	51.49 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	29.56 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0